Dimenhydrinate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for dimenhydrinate and what is the scope of patent protection?
Dimenhydrinate
is the generic ingredient in one branded drug marketed by Baxter Hlthcare, Fresenius Kabi Usa, Watson Labs, Watson Labs Teva, Wyeth Ayerst, Alra, Heather, and Nexgen Pharma Inc, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.There are five drug master file entries for dimenhydrinate. One supplier is listed for this compound.
Summary for dimenhydrinate
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 8 |
| NDAs: | 9 |
| Drug Master File Entries: | 5 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 72 |
| Clinical Trials: | 21 |
| Patent Applications: | 6,731 |
| Drug Prices: | Drug price trends for dimenhydrinate |
| What excipients (inactive ingredients) are in dimenhydrinate? | dimenhydrinate excipients list |
| DailyMed Link: | dimenhydrinate at DailyMed |
Recent Clinical Trials for dimenhydrinate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| The University of The West Indies | Early Phase 1 |
| Ciusss de L'Est de l'Île de Montréal | N/A |
| IWK Health Centre | Phase 4 |
Medical Subject Heading (MeSH) Categories for dimenhydrinate
Anatomical Therapeutic Chemical (ATC) Classes for dimenhydrinate
US Patents and Regulatory Information for dimenhydrinate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | DIMENHYDRINATE | dimenhydrinate | TABLET;ORAL | 085166-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Ayerst | DIMENHYDRINATE | dimenhydrinate | INJECTABLE;INJECTION | 084316-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Baxter Hlthcare | DIMENHYDRINATE | dimenhydrinate | INJECTABLE;INJECTION | 084767-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs Teva | DIMENHYDRINATE | dimenhydrinate | INJECTABLE;INJECTION | 080615-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | DIMENHYDRINATE | dimenhydrinate | INJECTABLE;INJECTION | 083531-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Fresenius Kabi Usa | DIMENHYDRINATE | dimenhydrinate | INJECTABLE;INJECTION | 040519-001 | Jun 23, 2004 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
